MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, ENTA made $18,615K in revenue. -$11,938K in net income. Net profit margin of -64.13%.

Income Overview

Revenue
$18,615K
Net Income
-$11,938K
Net Profit Margin
-64.13%
EPS
-$0.42
Unit: Thousand (K) dollars

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Total revenue
18,615 16,042 18,314 14,926
Research and development
20,859 25,733 27,210 28,065
General and administrative
9,009 11,274 9,997 11,388
Total operating expenses
29,868 37,007 37,207 39,453
Loss from operations
-11,253 -20,964 -18,893 -24,527
Interest expense
3,083 2,175 1,618 1,714
Interest and investment income, net
2,422 2,433 2,285 2,292
Change in fair value of series 1 nonconvertible preferred stock
-10 --
Total other (expense) income, net
-661 278 667 578
Loss before income taxes
-11,914 -20,687 -18,226 -23,949
Income tax (expense) benefit
24 -192 29 -1,305
Net loss
-11,938 -20,495 -18,255 -22,644
Basic
28,748,000 -21,355,332 21,377,000 21,355,000
Earnings per share, basic
-0.42 -0.965 -0.85 -1.06
Earnings per share, diluted
-0.42 -0.965 -0.85 -1.06
Weighted average number of shares outstanding, diluted
28,748,000 -21,355,332 21,377,000 21,355,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$11,938K Income tax (expense)benefit$24K Loss before incometaxes-$11,914K Total other (expense)income, net-$661K Loss from operations-$11,253K Interest and investmentincome, net$2,422K Total revenue$18,615K Interest expense$3,083K Total operatingexpenses$29,868K General andadministrative$9,009K Research and development$20,859K

ENANTA PHARMACEUTICALS INC (ENTA)

ENANTA PHARMACEUTICALS INC (ENTA)